Citadel Advisors »

Eiger Biopharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Eiger Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eiger Biopharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eiger Biopharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2k 14k 0.22
2023-03-31 $75k 84k 0.90
2022-12-31 $314k 266k 1.18
2022-06-30 $350k 56k 6.30
2022-03-31 $515k 62k 8.31
2021-12-31 $618k 119k 5.19
2021-09-30 $516k 77k 6.68
2021-06-30 $336k 39k 8.52
2021-03-31 $8.4M 944k 8.87
2020-12-31 $13M 1.1M 12.29
2020-09-30 $7.9M 974k 8.14
2020-06-30 $8.5M 883k 9.60
2020-03-31 $5.8M 853k 6.80
2019-12-31 $6.5M 435k 14.90
2019-09-30 $4.4M 430k 10.25
2019-06-30 $3.2M 299k 10.61